Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd. announced that it has signed an agreement with Careica Health. Under the agreement, patients will be referred from Careica's 26 homecare locations which span the provinces of Manitoba, Saskatchewan, Alberta, and British Columbia to an initial four sites which will operate the Oventus Lab in Lab business model. The agreement extends Careica's well known SLEEP program which will now include Oventus' O2Vent oral appliance therapy as an alternative for CPAP-intolerant individuals. Once fully deployed, each location expects to order a minimum of 20 O2Vent Optima devices per month. The agreement has a term of three years, with an automatic three year renewal, unless a party elects not to renew no later than 180 days prior to the end of the three year period. These recent agreements take the total number of locations contracted under Oventus' Lab in Lab model to 49.